Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by NightHawk Biosciences

News headline image
NightHawk Biosciences Completes Name Change to Scorpius Holdings; Trading to Commence Under “SCPX” Effective at the Market Open Today
From NightHawk Biosciences
Via GlobeNewswire
News headline image
NightHawk’s Scorpius BioManufacturing Subsidiary Announces the Promotion of Joe Payne to President and Chief Operating Officer
From NightHawk Biosciences
Via GlobeNewswire
News headline image
NightHawk Receives Proceeds of $3.25 Million in Connection with Sale of Non-Core Intellectual Property and Issuance of a Low Interest Bearing Note
From NightHawk Biosciences
Via GlobeNewswire
News headline image
NightHawk’s Scorpius BioManufacturing Subsidiary Awarded Multimillion- Dollar Contract with a Publicly Traded Biotech Company to Support its Phase 2 Clinical Program
From NightHawk Biosciences
Via GlobeNewswire
News headline image
NightHawk’s Scorpius BioManufacturing Subsidiary Commences Work on Preclinical Program for New Client
From NightHawk Biosciences
Via GlobeNewswire
News headline image
NightHawk Biosciences Announces Planned Name Change to Scorpius Holdings, Reflecting Successful Transition to a Large Molecule Biomanufacturing CDMO
From NightHawk Biosciences
Via GlobeNewswire
News headline image
NightHawk Biosciences Commences Work on Multi-Million-Dollar Development and Manufacturing Agreement For a Leading National University
From NightHawk Biosciences
Via GlobeNewswire
News headline image
NightHawk Biosciences Announces Completion of Demonstration Run for a Top-Tier NIH and DTRA Funded Research University
From NightHawk Biosciences
Via GlobeNewswire
News headline image
NightHawk Biosciences Announces Major Milestone with Completion of Manufacturing Run for a Premier U.S.-Based Biopharmaceutical Company
From NightHawk Biosciences
Via GlobeNewswire
News headline image
NightHawk Biosciences Announces Strategic Shift into a Pure-Play Large Molecule Biomanufacturing CDMO to Capitalize on Rapid Growth in Sales Pipeline along with Divestiture of Non-Core Assets
From NightHawk Biosciences
Via GlobeNewswire
News headline image
NightHawk Biosciences Provides Q3 2023 Business Update
From NightHawk Biosciences
Via GlobeNewswire
News headline image
NightHawk Biosciences Provides Q2 2023 Business Update
From NightHawk Biosciences
Via GlobeNewswire
News headline image
NightHawk Biosciences Provides Q1 2023 Business Update
From NightHawk Biosciences
Via GlobeNewswire
News headline image
NightHawk Biosciences Provides 2022 Year End Business Update
From NightHawk Biosciences
Via GlobeNewswire
News headline image
NightHawk Biosciences Provides Third Quarter 2022 Business Update
From NightHawk Biosciences
Via GlobeNewswire
News headline image
Nighthawk Biosciences’ Scorpion Subsidiary Announces Grand Opening of its San Antonio Facility
From NightHawk Biosciences
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.